IL-5 production by resident mucosal allergen-specific T cells in an explant model of allergic rhinitis

Summary Background Seasonal allergic rhinitis is a chronic inflammation in the nasal mucosa triggered by inhaled aeroallergens. The inflammatory reaction is controlled by allergen‐specific T cells, but where and how these T cells become activated is not fully understood. Objectives We wanted to dete...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental allergy Vol. 45; no. 8; pp. 1296 - 1304
Main Authors: Skrindo, I., Ballke, C., Gran, E., Johansen, F.-E., Baekkevold, E. S., Jahnsen, F. L.
Format: Journal Article
Language:English
Published: England Blackwell Publishing Ltd 01-08-2015
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background Seasonal allergic rhinitis is a chronic inflammation in the nasal mucosa triggered by inhaled aeroallergens. The inflammatory reaction is controlled by allergen‐specific T cells, but where and how these T cells become activated is not fully understood. Objectives We wanted to determine whether allergen‐specific T‐helper (Th) 2 cells are residing in the nasal mucosa under steady‐state conditions outside of the pollen season and, if so, whether these cells are activated locally in response to allergen challenge. Methods Mucosal biopsies from the lower turbinate were obtained out of season from patients with either birch‐ or grass‐pollen‐allergic rhinitis and from healthy controls. Cultured explant samples were challenged with relevant pollen extract or with a mix of overlapping 20‐mer peptides derived from the sequence of the major birch allergen, Betula verrucosa (Bet v) 1. After 24 h, culture medium was harvested for multiplex cytokine and tryptase analysis. Results Significant amounts of interleukin (IL)‐5 were secreted from resident cells in response to ex vivo allergen challenge in the allergic group only. No increase was observed for the other cytokines measured. Production of IL‐5 in response to both extract and the Bet v1‐derived peptide mix strongly suggested that T cells were a major source of IL‐5. Conclusion Our explant model indicated that local presentation of antigen to resident allergen‐specific Th2 cells is the early event in the pathogenesis of allergic rhinitis. These findings identify possible cellular targets for anti‐inflammatory treatment.
Bibliography:ark:/67375/WNG-0096MW05-Q
ArticleID:CEA12543
Table S1. Clinical characterization of allergic subjects.Figure S1. Detection of Th2-polarized CD8+ T cells in steady-state nasal mucosa.
istex:6CA3D2824E72B30261EEF8E34707013DC6AD18AB
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0954-7894
1365-2222
DOI:10.1111/cea.12543